Table 1 Baseline characteristics of the included patients in the final statistical analysis
TEA/PCIA Group | TEA Group | P | |
|---|---|---|---|
Age (y) | 56.1 ± 11.1 | 54.6 ± 13.0 | 0.569 |
Sex (Male: Female) | 36:8 | 33:7 | 0.705 |
BMI (kg m−2) | 21.7 ± 2.8 | 22.2 ± 3.0 | 0.491 |
ASA I-II, n (%) | 44 | 42 | 0.924 |
ASA I, n (%) | 7 (16) | 7 (17) | — |
ASA II, n (%) | 37 (84) | 35 (83) | — |
Comorbidities, n (%) | 13 (29.5) | 13 (31.0) | 0.887 |
Diabetes, n (%) | 7 | 4 | — |
Hypertension, n (%) | 4 | 8 | — |
Respiratory, n (%) | 2 | 4 | — |
Surgical type, n (%) | 44 | 42 | 0.833 |
Liver surgery, n (%) | 21 (47) | 21 (50) | — |
Pancreaticoduodenectomy, n (%) | 10 (23) | 12 (28) | — |
Gastrointestinal surgery, n (%) | 7(16) | 5(12) | — |
Colorectal surgery, n (%) | 6 (14) | 4 (10) | — |
Incision type, n (%) | 44 | 42 | 0.657 |
Reversed L-shaped incision, n (%) | 1 (2.3) | 1 (2.4) | — |
Roof incision, n (%) | 19 (43.2) | 20 (47.6) | — |
Subcostal incision, n (%) | 2 (4.5) | 2 (4.8) | — |
Midline incision, n (%) | 15 (34.1) | 17 (40.4) | — |
Para-midline incision, n (%) | 7 (15.9) | 2 (4.8) | — |